Cyclin-Dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis
Journal of Clinical Investigation - United States
doi 10.1172/jci129277
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2019
Authors
Publisher
American Society for Clinical Investigation